Amphix Bio raises $12.5M seed round to advance peptide drug platform
PR Newswire —
CHICAGO, Dec. 18, 2025 /PRNewswire/ -- Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials and expand its pipeline to target additional neurological conditions. The funding comes...